HVC
SCMP

Healthcare Value Capital’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Healthcare Value Capital’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-51,630
Closed -$336K – 38
2014
Q3 		$336K Sell
51,630
-45,000
-47% -$299K 0.32% 28
2014
Q2 		$667K Buy
+96,630
New +$683K 0.56% 23

Other funds holding SCMP

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Healthcare Value Capital's SCMP Position: Q4 2014 in Review

Healthcare Value Capital sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2014, closing a stake of 51,630 shares — an estimated $336K sold.

Healthcare Value Capital first reported a position in SCMP in Q2 2014 and held it in 2 quarters. The position peaked at $667K in Q2 2014. 91 funds tracked by Wall St. Rank hold SCMP as of Q4 2014.

  • Healthcare Value Capital reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Healthcare Value Capital sold 51,630 Sucampo Pharmaceuticals, Inc. shares in Q4 2014, an estimated $336K.
  • Healthcare Value Capital first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2014 and held it in 2 quarters.
  • Healthcare Value Capital's Sucampo Pharmaceuticals, Inc. position peaked at $667K in Q2 2014.
  • 91 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2014.

Based on Healthcare Value Capital's 13F filing for Q4 2014, filed 13 Feb 2015.